Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee advances trigger bill to allow FDA‑approved psilocybin medicine to be prescribed in Colorado
Summary
House Bill 25-1063 would make an FDA‑approved prescription drug containing crystalline polymorph psilocybin legal to prescribe and dispense in Colorado upon FDA approval and subsequent DEA rescheduling. The committee advanced the bill after bipartisan sponsorship and mixed public testimony about market and fiscal effects.
The House Committee on Health & Human Services voted to send House Bill 25-1063 to the Committee of the Whole after hearing testimony both supporting and opposing a trigger mechanism that would let Coloradans access an FDA‑approved psilocybin-based prescription medicine if and when the drug is approved and rescheduled by federal authorities.
Sponsoring Representative Brian Hartsook described HB 25-1063 as a “trigger” bill: if the United States Food and Drug Administration approves a prescription drug containing crystalline polymorph psilocybin and the Drug Enforcement Administration reschedules it for medical use, the bill would allow that FDA‑approved product to be prescribed, dispensed,…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
